We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Rejects Aegerion Plea Deal for Deceptive Cholesterol Drug Marketing
Judge Rejects Aegerion Plea Deal for Deceptive Cholesterol Drug Marketing
A federal judge blocked Aegerion’s proposed $36 million deal to settle claims of illegal marketing tactics for its cholesterol drug Juxtapid, ordering the case to trial.